耳鼻咽喉科用ハンドヘルド機器の世界市場：洞察、競合情勢、市場予測：2030年

世界の耳鼻咽喉科用ハンドヘルド機器の市場規模は、2024年から2030年までの予測期間中に6.36％のCAGRで拡大すると予測されています。耳鼻咽喉科（耳、鼻、喉）疾患の負担増は、認知度の向上やスクリーニングプログラムの増加と相まって、耳鼻咽喉科用ハンドヘルド機器市場を大きく牽引しています。さらに、市場開発の主な参入企業による製品開発活動の急増が技術革新を促進し、多様な消費者ニーズに対応する先進的で使いやすく、カスタマイズ可能な耳鼻咽喉科用ハンドヘルド機器の導入につながっています。これらの要因が相まって、堅調な市場環境が形成され、需要と供給の双方が促進され、2024年から2030年までの予測期間中に耳鼻咽喉科用ハンドヘルド機器産業が大きく成長することになります。

世界保健機関（WHO）の最新データ（2024年）によると、2050年までに25億人近くがある程度の難聴を経験し、少なくとも7億人が聴覚リハビリを必要とすると予測されています。10億人以上の若年成人が、安全でない聞き方により、回避可能な永続的難聴の危険にさらされています。難聴者の80%近くが中低所得国に住んでいた。難聴の有病率は年齢とともに上昇し、60歳以上の高齢者の25％以上が難聴に罹患しています。

世界の難聴人口の増加は、耳鼻咽喉科用ハンドヘルド機器市場を牽引する重要な要因です。高齢化、環境要因、その他の健康状態により難聴が広まるにつれ、効果的な診断・モニタリングツールに対する需要が高まっています。耳鏡やオージオメータなどの耳鼻咽喉科用ハンドヘルド機器は、聴覚障害の早期発見と管理に重要な役割を果たしています。難聴を診断・評価するための正確で携帯可能な使いやすい機器へのニーズの高まりが、先進的なハンドヘルド技術の開発における技術革新と投資の原動力となっています。

当レポートでは、世界の耳鼻咽喉科用ハンドヘルド機器市場について調査し、市場の概要とともに、製品タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 耳鼻咽喉科用ハンドヘルド機器市場レポートのイントロダクション

第2章 耳鼻咽喉科用ハンドヘルド機器市場のエグゼクティブサマリー

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 耳鼻咽喉科用ハンドヘルド機器市場の主な要因分析

• 耳鼻咽喉科用ハンドヘルド機器の市場促進要因
• 耳鼻咽喉科用ハンドヘルド機器の市場抑制要因と課題
• 耳鼻咽喉科用ハンドヘルド機器の市場機会

第6章 耳鼻咽喉科用ハンドヘルド機器市場におけるポーターのファイブフォース分析

第7章 耳鼻咽喉科用ハンドヘルド機器市場の評価

• 製品タイプ別
• エンドユーザー別
• 地域別

第8章 耳鼻咽喉科用ハンドヘルド機器市場の企業および製品プロファイル

• Integra Lifesciences
• Stryker
• Medtronic plc.
• SPIGGLE & THEIS Medizintechnik GmbH
• Olympus Corporation
• PRO-MED Instrumente GmbH
• B. Braun Melsungen AG
• Grace Medical
• Heinz Kurz GmbH
• Summit Medical LLC
• Advin Healthcare
• FENTEX medical GmbH.
• Rica Surgical Products, Inc.
• BLINK MEDICAL
• Symmetry Surgical Inc.
• Bailey Instruments Ltd.
• Tonglu WANHE Medical Instrument Co.,Ltd.
• Moonlight Surgical Works
• SOLCO BIOMEDICAL CO., LTD.
• ELMED Incorporated

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: ENT Handheld Instruments Market in Global (2021-2030)
• Table 3: ENT Handheld Instruments Market in Global by Product Type (2021-2030)
• Table 4: ENT Handheld Instruments Market in Global by End User (2021-2030)
• Table 5: ENT Handheld Instruments Market in Global by Geography (2021-2030)
• Table 6: ENT Handheld Instruments Market in North America (2021-2030)
• Table 7: ENT Handheld Instruments Market in the United States (2021-2030)
• Table 8: ENT Handheld Instruments Market in Canada (2021-2030)
• Table 9: ENT Handheld Instruments Market in Mexico (2021-2030)
• Table 10: ENT Handheld Instruments Market in Europe (2021-2030)
• Table 11: ENT Handheld Instruments Market in France (2021-2030)
• Table 12: ENT Handheld Instruments Market in Germany (2021-2030)
• Table 13: ENT Handheld Instruments Market in United Kingdom (2021-2030)
• Table 14: ENT Handheld Instruments Market in Italy (2021-2030)
• Table 15: ENT Handheld Instruments Market in Spain (2021-2030)
• Table 16: ENT Handheld Instruments Market in the Rest of Europe (2021-2030)
• Table 17: ENT Handheld Instruments Market in Asia-Pacific (2021-2030)
• Table 18: ENT Handheld Instruments Market in China (2021-2030)
• Table 19: ENT Handheld Instruments Market in Japan (2021-2030)
• Table 20: ENT Handheld Instruments Market in India (2021-2030)
• Table 21: ENT Handheld Instruments Market in Australia (2021-2030)
• Table 22: ENT Handheld Instruments Market in South Korea (2021-2030)
• Table 23: ENT Handheld Instruments Market in Rest of Asia-Pacific (2021-2030)
• Table 24: ENT Handheld Instruments Market in the Rest of the World (2021-2030)
• Table 25: ENT Handheld Instruments Market in the Middle East (2021-2030)
• Table 26: ENT Handheld Instruments Market in Africa (2021-2030)
• Table 27: ENT Handheld Instruments Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: ENT Handheld Instruments Market in Global (2021-2030)
• Figure 3: ENT Handheld Instruments Market in Global by Product Type (2021-2030)
• Figure 4: ENT Handheld Instruments Market in Global by End User (2021-2030)
• Figure 5: ENT Handheld Instruments Market in Global by Geography (2021-2030)
• Figure 6: ENT Handheld Instruments Market in North America (2021-2030)
• Figure 7: ENT Handheld Instruments Market in the United States (2021-2030)
• Figure 8: ENT Handheld Instruments Market in Canada (2021-2030)
• Figure 9: ENT Handheld Instruments Market in Mexico (2021-2030)
• Figure 10: ENT Handheld Instruments Market in Europe (2021-2030)
• Figure 11: ENT Handheld Instruments Market in France (2021-2030)
• Figure 12: ENT Handheld Instruments Market in Germany (2021-2030)
• Figure 13: ENT Handheld Instruments Market in United Kingdom (2021-2030)
• Figure 14: ENT Handheld Instruments Market in Italy (2021-2030)
• Figure 15: ENT Handheld Instruments Market in Spain (2021-2030)
• Figure 16: ENT Handheld Instruments Market in the Rest of Europe (2021-2030)
• Figure 17: ENT Handheld Instruments Market in Asia-Pacific (2021-2030)
• Figure 18: ENT Handheld Instruments Market in China (2021-2030)
• Figure 19: ENT Handheld Instruments Market in Japan (2021-2030)
• Figure 20: ENT Handheld Instruments Market in India (2021-2030)
• Figure 21: ENT Handheld Instruments Market in Australia (2021-2030)
• Figure 22: ENT Handheld Instruments Market in South Korea (2021-2030)
• Figure 23: ENT Handheld Instruments Market in Rest of Asia-Pacific (2021-2030)
• Figure 24: ENT Handheld Instruments Market in the Rest of the World (2021-2030)
• Figure 25: ENT Handheld Instruments Market in the Middle East (2021-2030)
• Figure 26: ENT Handheld Instruments Market in Africa (2021-2030)
• Figure 27: ENT Handheld Instruments Market in South America (2021-2030)
• Figure 28: Market Drivers
• Figure 29: Market Barriers
• Figure 30: Market Opportunities
• Figure 31: PORTER'S Five Force Analysis

ENT Handheld Instruments by Product Type (Otology Instruments, Rhinology Instruments, and Laryngeal Instruments), End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the rising burden of ENT disorders, increasing awareness and screening programs, and technological advancements leading to increase in product development activities across the globe.

The global ENT handheld instruments market is expected to grow at a CAGR of 6.36% during the forecast period from 2024 to 2030. The rising burden of ENT (ear, nose, and throat) disorders, coupled with increasing awareness and screening programs, significantly drives the market for ENT handheld instruments. Additionally, the surge in product development activities by key market players fosters innovation, resulting in the introduction of advanced, user-friendly, and customizable ENT handheld instruments that meet diverse consumer needs. Together, these factors create a robust market environment, driving both demand and supply, and leading to significant growth in the ENT handheld instruments industry during the forecast period from 2024 to 2030.

ENT Handheld Instruments Market Dynamics:

According to the latest data provided by the World Health Organization (2024), by 2050, nearly 2.5 billion people were projected to have experienced some degree of hearing loss, with at least 700 million requiring hearing rehabilitation. Over 1 billion young adults were at risk of permanent, avoidable hearing loss due to unsafe listening practices. Nearly 80% of individuals with disabling hearing loss had lived in low- and middle-income countries. The prevalence of hearing loss had increased with age, with over 25% of those older than 60 years being affected by disabling hearing loss.

Furthermore, as per the recent data and stats provided by the Australian Government Department of Health and Aged Care (2024), approximately 3.6 million people had some level of hearing loss. As Australia's population aged, the number of individuals with hearing impairment was expected to double, reaching an estimated 7.8 million by 2060.

The increasing prevalence of hearing loss globally is a significant factor propelling the market for ENT handheld instruments. As hearing loss becomes more widespread due to aging populations, environmental factors, and other health conditions, the demand for effective diagnostic and monitoring tools rises. ENT handheld instruments, such as otoscopes and audiometers, play a crucial role in the early detection and management of hearing impairments. The growing need for accurate, portable, and user-friendly devices to diagnose and assess hearing loss drives innovation and investment in the development of advanced handheld technologies.

According to the latest data provided by GLOBOCAN (2024), in 2022 globally the new cases of larynx cancer was 189,000 and was estimated to rise to 228,000 by 2030. As per the same source in 2022 there were approximately 40,000 new cases of larynx cancer in Europe. Furthermore, as per the same source, in 2022 globally the new cases of oropharynx and nasopharynx cancer was 22700 and is expected to rise to 265000.

Larynx cancer, oropharynx cancer, and nasopharynx cancer are all significant contributors to the rising demand for ENT handheld instruments, as these cancers directly affect critical areas of the head and neck region. The need for precise diagnostic and therapeutic procedures in treating these cancers has heightened the demand for advanced handheld instruments such as laryngoscopes, nasopharyngoscopes, and oropharyngoscopes. These cancers often require intricate surgical interventions and frequent biopsies, necessitating the use of specialized instruments designed for access to hard-to-reach areas within the throat, ear, and throat thereby escalating the demand for ENT handheld instruments across the region.

However, the risk of injury, discomfort, infection, limited visualization, and stringent regulatory concerns for product approval may hinder the future market of ENT handheld instruments.

ENT Handheld Instruments Market Segment Analysis:

ENT Handheld Instruments by Product Type (Otology Instruments, Rhinology Instruments, and Laryngeal Instruments), End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of ENT handheld instruments market the rhinology instruments are expected to hold a significant share in 2023. Rhinology instruments are playing a significant role in driving the overall growth of the ENT handheld instruments market, largely due to the increasing prevalence of nasal and sinus conditions and the growing demand for minimally invasive procedures. The rise in chronic rhino sinusitis, allergic rhinitis, and other nasal disorders has led to a surge in demand for specialized rhinology instruments, such as nasal speculums, septal elevators, nasal forceps, and sinus seekers. According to the recent data and stats provided by Centre for Disease Control and Prevention (2022), approximately, 28.9 million of adults were diagnosed with sinusitis in the United States.

Additionally, these tools are essential for performing a variety of diagnostic and therapeutic procedures, including endoscopic sinus surgery, septoplasty, and turbinate reduction. The trend towards minimally invasive surgeries is particularly noteworthy, as patients increasingly seek treatments that offer faster recovery times and less postoperative discomfort. This shift has prompted manufacturers to innovate and develop advanced rhinology instruments that are more precise, ergonomic, and adaptable to various surgical techniques. Furthermore, their precision and ability to provide detailed visualization of the nasal cavity and sinuses, which enhances diagnostic accuracy. Modern rhinology instruments, such as flexible endoscopes with high-definition cameras, allow for real-time imaging, enabling physicians to conduct thorough examinations and make more informed decisions. This improved diagnostic capability leads to better patient outcomes and more targeted treatments.

Additionally, an increase in product development activities are also anticipated to augment the rhinology instrument market growth For instance, in September 2023 Olympus Corporation launched Vathin E-SteriScope(TM) single-use flexible video rhinolaryngoscope for use in diagnostic and therapeutic otorhinolaryngological procedures.

Therefore, owing to the above-mentioned factors, the rhinology instrument category is expected to generate considerable revenue thereby pushing the overall growth of the global ENT handheld instruments market during the forecast period.

North America is expected to dominate the overall ENT Handheld Instruments market:

North America is expected to account for the highest proportion of the ENT handheld instruments market in 2023, out of all regions. This can be ascribed to the increasing prevalence of hearing loss, increasing prevalence of thyroid cancer, rising number of cases of sinusitis, laryngeal and pharyngeal cancer, increase government initiatives coupled with increased awareness programs for ENT disorders, and the presence of key market players engaged in strategic activities across the region are expected to escalate the market of ENT handheld instruments during the forecast period.

According to the most recent estimates provided by the American Cancer Society, in 2024 there were approximately 12,650 new cases of laryngeal cancer in which 10,030 were men and 2,620 were women in the United States. Additionally, as per the data provided by the GLOBOCAN (2024) in 2022 there were approximately 13,000 new cases of laryngeal cancer and about 18,000 new cases of oropharynx and nasopharynx cancer in North America. Laryngeal cancer, which affects the voice box, and oropharyngeal and nasopharyngeal cancers, which involve the throat and nasal passages, often require detailed visualization and biopsy procedures to diagnose and monitor progression. Handheld instruments such as flexible endoscopes, laryngoscopes, and fiber-optic scopes are crucial for providing high-resolution images of the affected areas, enabling clinicians to detect tumors at an early stage, plan surgical interventions, and guide radiation therapy thereby boosting the overall market of ENT handheld instruments across the region.

Furthermore, as per the recent data provided by National Council of Aging (2023), hearing loss affected about 60.7 million Americans aged 12 and older accounting approximately 15.5% (44.1 million) of American adults aged 20 and older had some level of hearing loss. Handheld devices such as otoscopes, audiometers, and tympanometers are critical in evaluating the health of the ear canal, middle ear, and hearing functions. These instruments enable healthcare providers to conduct thorough examinations, identify the underlying causes of hearing loss, and tailor appropriate treatment plans thereby boosting the overall market of ENT handheld instruments across the region.

Therefore, the above-mentioned factors are expected to bolster the growth of the ENT handheld instruments market in North America during the forecast period.

ENT Handheld Instruments Market Key Players:

Some of the key market players operating in the ENT handheld instruments market include Integra Lifesciences, Stryker, Medtronic, SPIGGLE & THEIS Medizintechnik GmbH, Olympus, PRO-MED Instrumente GmbH, B. Braun Melsungen AG, Grace Medical, Heinz Kurz GmbH, Summit Medical LLC, Advin Healthcare, FENTEX medical GmbH., Rica Surgical Products, Inc., BLINK MEDICAL, Symmetry Surgical Inc., Bailey Instruments Ltd, Tonglu WANHE Medical Instrument Co.,Ltd, Moonlight Surgical Works, SOLCO BIOMEDICAL CO., LTD, ELMED Incorporated, BD, Teleflex Incorporated, and others.

Recent Developmental Activities in the ENT Handheld Instruments Market:

• In May 2024, Olympus, announced the release of the DVM-B2 Digital Video Monitor. This all-in-one video processor and monitor was designed for use with single-use endoscopes in bronchoscopy and ENT, including the H-SteriScope(TM) Single-use Flexible Bronchoscopes and the E-SteriScope(TM) Single-use Flexible Rhinolaryngoscopes.
• In September 2023 Penlon, a global producer of medical devices in UK launched new Diamond Video Laryngoscopes, a portable device which gives increased field of view as compared to other direct rigid laryngoscopes.

Key Takeaways From the ENT Handheld Instruments Market Report Study:

• Market size analysis for current ENT handheld instruments size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the ENT handheld instruments market.
• Various opportunities available for the other competitors in the ENT handheld instruments market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current ENT handheld instruments market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for ENT handheld instruments market growth in the coming future?

Target Audience who can be Benefited From This ENT Handheld Instruments Market Report Study:

• ENT handheld instruments product providers
• Research organizations and consulting companies
• ENT handheld instruments -related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in ENT handheld instruments
• Various end-users who want to know more about the ENT handheld instruments market and the latest technological developments in the ENT handheld instruments market.

Frequently Asked Questions for the ENT Handheld Instruments Market:

1. What are ENT handheld instruments?

• An ENT handheld instrument is a device which are majorly employed during various ENT surgeries and specialized according to the structure being operated on such as otology-handheld instruments, rhinology instruments, and others.

2. What is the market for ENT handheld instruments?

• The global ENT handheld instruments market is expected to grow at a CAGR of 6.36% during the forecast period from 2024 to 2030.

3. What are the drivers for the ENT handheld instruments market?

• The rising burden of ENT (ear, nose, and throat) disorders, coupled with increasing awareness and screening programs, significantly drives the market for ENT handheld instruments. Additionally, the surge in product development activities by key market players fosters innovation, resulting in the introduction of advanced, user-friendly, and customizable ENT handheld instruments that meet diverse consumer needs. Together, these factors create a robust market environment, driving both demand and supply, and leading to significant growth in the ENT handheld instruments industry during the forecast period from 2024 to 2030.

4. Who are the key players operating in the ENT Handheld Instruments market?

• Some of the key market players operating in the ENT handheld instruments market include Integra Lifesciences, Stryker, Medtronic, SPIGGLE & THEIS Medizintechnik GmbH, Olympus, PRO-MED Instrumente GmbH, B. Braun Melsungen AG, Grace Medical, Heinz Kurz GmbH, Summit Medical LLC, Advin Healthcare, FENTEX medical GmbH., Rica Surgical Products, Inc., BLINK MEDICAL, Symmetry Surgical Inc., Bailey Instruments Ltd, Tonglu WANHE Medical Instrument Co.,Ltd, Moonlight Surgical Works, SOLCO BIOMEDICAL CO., LTD, ELMED Incorporated, BD, Teleflex Incorporated, and others.

5. Which region has the highest share in the ENT Handheld Instruments market?

• North America is expected to account for the highest proportion of the ENT handheld instruments market in 2023, out of all regions. This can be ascribed to the increasing prevalence of hearing loss, increasing prevalence of thyroid cancer, rising number of cases of sinusitis, laryngeal and pharyngeal cancer, increase government initiatives coupled with increased awareness programs for ENT disorders, and the presence of key market players engaged in strategic activities across the region are expected to escalate the market of ENT handheld instruments during the forecast period.

Table of Contents

1. ENT Handheld Instruments Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. ENT Handheld Instruments Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. ENT Handheld Instruments Market Key Factors Analysis

• 5.1. ENT Handheld Instruments Market Drivers
  • 5.1.1. Rising burden of ENT disorders
  • 5.1.2. Increasing awareness and screening programs
  • 5.1.3. Technological advancements leading to increase in product development activities
• 5.2. ENT Handheld Instruments Market Restraints and Challenges
  • 5.2.1. Risk of injury, discomfort, infection, and limited visualization
  • 5.2.2. Stringent regulatory concerns for product approval
• 5.3. ENT Handheld Instruments Market Opportunities
  • 5.3.1. Integration with digital devices telemedicine and remote patient monitoring

6. ENT Handheld Instruments Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. ENT Handheld Instruments Market Assessment

• 7.1. By Product Type
  • 7.1.1. Otology Handheld Instruments
  • 7.1.2. Rhinology Handheld Instruments
  • 7.1.3. Laryngeal Handheld Instruments
• 7.2. By End User
  • 7.2.1. Hospitals
  • 7.2.2. Specialty Clinics
  • 7.2.3. Ambulatory Surgical Centers
• 7.3. By Geography
  • 7.3.1. North America
    • 7.3.1.1. United States ENT Handheld Instruments Market Size in USD Million (2021-2030)
    • 7.3.1.2. Canada ENT Handheld Instruments Market Size in USD Million (2021-2030)
    • 7.3.1.3. Mexico ENT Handheld Instruments Market Size in USD Million (2021-2030)
  • 7.3.2. Europe
    • 7.3.2.1. France ENT Handheld Instruments Market Size in USD Million (2021-2030)
    • 7.3.2.2. Germany ENT Handheld Instruments Market Size in USD Million (2021-2030)
    • 7.3.2.3. United Kingdom ENT Handheld Instruments Market Size in USD Million (2021-2030)
    • 7.3.2.4. Italy ENT Handheld Instruments Market Size in USD Million (2021-2030)
    • 7.3.2.5. Spain ENT Handheld Instruments Market Size in USD Million (2021-2030)
    • 7.3.2.6. Rest of Europe ENT Handheld Instruments Market Size in USD Million (2021-2030)
  • 7.3.3. Asia-Pacific
    • 7.3.3.1. China ENT Handheld Instruments Market Size in USD Million (2021-2030)
    • 7.3.3.2. Japan ENT Handheld Instruments Market Size in USD Million (2021-2030)
    • 7.3.3.3. India ENT Handheld Instruments Market Size in USD Million (2021-2030)
    • 7.3.3.4. Australia ENT Handheld Instruments Market Size in USD Million (2021-2030)
    • 7.3.3.5. South Korea ENT Handheld Instruments Market Size in USD Million (2021-2030)
    • 7.3.3.6. Rest of Asia-Pacific ENT Handheld Instruments Market Size in USD Million (2021-2030)
  • 7.3.4. Rest of the World (RoW)
    • 7.3.4.1. Middle East ENT Handheld Instruments Market Size in USD Million (2021-2030)
    • 7.3.4.2. Africa ENT Handheld Instruments Market Size in USD Million (2021-2030)
    • 7.3.4.3. South America ENT Handheld Instruments Market Size in USD Million (2021-2030)

8. ENT Handheld Instruments Market Company and Product Profiles

• 8.1. Integra Lifesciences
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Stryker
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Medtronic plc.
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. SPIGGLE & THEIS Medizintechnik GmbH
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Olympus Corporation
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. PRO-MED Instrumente GmbH
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. B. Braun Melsungen AG
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Grace Medical
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Heinz Kurz GmbH
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Summit Medical LLC
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Advin Healthcare
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. FENTEX medical GmbH.
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Rica Surgical Products, Inc.
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. BLINK MEDICAL
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Symmetry Surgical Inc.
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. Bailey Instruments Ltd.
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy
• 8.17. Tonglu WANHE Medical Instrument Co.,Ltd.
  • 8.17.1. Company Overview
  • 8.17.2. Company Snapshot
  • 8.17.3. Financial Overview
  • 8.17.4. Product Listing
  • 8.17.5. Entropy
• 8.18. Moonlight Surgical Works
  • 8.18.1. Company Overview
  • 8.18.2. Company Snapshot
  • 8.18.3. Financial Overview
  • 8.18.4. Product Listing
  • 8.18.5. Entropy
• 8.19. SOLCO BIOMEDICAL CO., LTD.
  • 8.19.1. Company Overview
  • 8.19.2. Company Snapshot
  • 8.19.3. Financial Overview
  • 8.19.4. Product Listing
  • 8.19.5. Entropy
• 8.20. ELMED Incorporated
  • 8.20.1. Company Overview
  • 8.20.2. Company Snapshot
  • 8.20.3. Financial Overview
  • 8.20.4. Product Listing
  • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us